Locally acting antiandrogens for topical treatment of acne

Aranda Pharma is a preclinical stage pharmaceutical company. We are developing novel non-steroidal small molecule inhibitors of the androgen receptor, that are advanced as locally acting anti-androgens for the  topical treatment of acne.



Aranda Pharma organized an investor webinar on December 21st. The webinar recording can be viewed above or from link below.

in English:


in Finnish:



Aranda Pharma is hosting an investor webinar on Tuesday, 21 December at 6 pm EET.

Register here


Aranda Pharma järjestää sijoittajille webinaarin tiistaina 21.12. klo 17.

Ilmoittaudu tästä


2021 - December

We are fundraising. The round is open until December 30, 2021. https://invest.invesdor.com/en/pitches/1102 


Aranda Pharma Ltd received a grant from the Centre for Economic Development, Transport and the Environment (ELY Centre). The grant will be used to strengthen and explore international business potential of company’s ADA-308 program.